South-Eastern Asia vs Sri Lanka: Proportion of the target population who received
South-Eastern Asia
81.0%
in 2024
Sri Lanka
98.0%
in 2024
South-Eastern Asia rank
16th
Sri Lanka rank
17th
Proportion of the target population who received over time
- South-Eastern Asia
- Sri Lanka
How they compare
Sri Lanka currently reports 98.0% against 81.0% in South-Eastern Asia, a difference of 17.0%.
That makes Sri Lanka's figure about 1.2 times South-Eastern Asia's.
Across all 24 years both countries report, Sri Lanka has been ahead every year.
South-Eastern Asia ranks 16th and Sri Lanka ranks 17th of 37 groups.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South-Eastern Asia | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.1% | 90.8% | 60.7% | Sri Lanka |
| 2010s | 67.7% | 99.0% | 31.3% | Sri Lanka |
| 2020s | 71.8% | 97.6% | 25.8% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, South-Eastern Asia or Sri Lanka?
- Sri Lanka, at 98.0% against 81.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received between South-Eastern Asia and Sri Lanka?
- 17.0%, with Sri Lanka ahead.
- How many years of comparable data are there for South-Eastern Asia and Sri Lanka?
- 24 years are reported by both, from 2001 to 2024.
- How do South-Eastern Asia and Sri Lanka rank globally for proportion of the target population who received?
- South-Eastern Asia ranks 16th and Sri Lanka ranks 17th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.